Advances in Myelofibrosis Treatment

home / investigator-perspectives / advances-in-myelofibrosis-treatment

Expert hematologist Stephen Oh, MD, PhD, provides an overview of myelofibrosis, and discusses how new data from ASH 2022 affect the treatment landscape.

Stephen Oh, MD, PhD, an expert on myelofibrosis

EP. 1: Myelofibrosis Types and Presentations

Stephen Oh, MD, PhD
January 23rd 2023

Stephen Oh, MD, PhD, explains the different types of myelofibrosis and describes the signs and symptoms.

Watch

Stephen Oh, MD, PhD, an expert on myelofibrosis

EP. 2: Molecular Targets and Transplant Considerations in Myelofibrosis

Stephen Oh, MD, PhD
February 8th 2023

An expert hematologist discusses important molecular targets in myelofibrosis, and when to consider transplant.

Watch

Stephen Oh, MD, PhD, an expert on myelofibrosis

EP. 3: Treatment Options for Patients with Myelofibrosis: Pacritinib, Fedratinib, and Ruxolitinib

Stephen Oh, MD, PhD
February 8th 2023

Stephen Oh, MD, PhD, gives a comprehensive review of the available treatment options for myelofibrosis.

Watch

Stephen Oh, MD, PhD, an expert on myelofibrosis

EP. 4: A New Option Being Explored for Myelofibrosis

Stephen Oh, MD, PhD
February 8th 2023

An overview of momelotinib, which was recently submitted for FDA approval, and how myelofibrosis treatments affect quality of life.

Watch

Stephen Oh, MD, PhD, an expert on myelofibrosis

EP. 5: Approaching Treatment Selection and Sequencing in Myelofibrosis

Stephen Oh, MD, PhD
February 8th 2023

Stephen Oh, MD, PhD, describes the factors that influence treatment selection in myelofibrosis, and then reviews sequencing strategies.

Watch

Stephen Oh, MD, PhD, an expert on myelofibrosis

EP. 6: Unmet Needs and Promising New Therapies in Myelofibrosis

Stephen Oh, MD, PhD
February 8th 2023

Expert hematologist, Stephen Oh, MD, PhD, talks about unmet needs and promising new therapies in myelofibrosis.

Watch